KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Return on Invested Capital (2018 - 2025)

Historic Return on Invested Capital for Biomarin Pharmaceutical (BMRN) over the last 15 years, with Q3 2025 value amounting to 0.08%.

  • Biomarin Pharmaceutical's Return on Invested Capital rose 300.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.07% for FY2024, which is 400.0% up from last year.
  • As of Q3 2025, Biomarin Pharmaceutical's Return on Invested Capital stood at 0.08%, which was up 300.0% from 0.1% recorded in Q2 2025.
  • Biomarin Pharmaceutical's 5-year Return on Invested Capital high stood at 0.2% for Q2 2021, and its period low was 0.02% during Q4 2021.
  • In the last 5 years, Biomarin Pharmaceutical's Return on Invested Capital had a median value of 0.03% in 2022 and averaged 0.05%.
  • Examining YoY changes over the last 5 years, Biomarin Pharmaceutical's Return on Invested Capital showed a top increase of 1600bps in 2021 and a maximum decrease of -1900bps in 2021.
  • Quarter analysis of 5 years shows Biomarin Pharmaceutical's Return on Invested Capital stood at 0.02% in 2021, then surged by 304bps to 0.03% in 2022, then decreased by -8bps to 0.03% in 2023, then skyrocketed by 126bps to 0.07% in 2024, then increased by 13bps to 0.08% in 2025.
  • Its last three reported values are 0.08% in Q3 2025, 0.1% for Q2 2025, and 0.08% during Q1 2025.